Palvella Therapeutics, Inc. Increase (Decrease) in Income Taxes
Palvella Therapeutics, Inc. (PVLA) reported Increase (Decrease) in Income Taxes of $10.11 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2016-11-10
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for the quarter ending 2015-09-30 was $12.47K.
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for the quarter ending 2015-06-30 was -$181.00.
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for the quarter ending 2015-03-31 was -$2.18K, a 104.32% decline year-over-year.
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for the quarter ending 2014-12-31 was -$1.12K.
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for fiscal 2014 was $47.94K.
- Palvella Therapeutics, Inc. increase (decrease) in income taxes for fiscal 2013 was -$14.82K.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month | Increase (Decrease) in Income Taxes 12 month |
|---|---|---|---|---|
| 2015-09-30 | $12.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $12.29K derived: sum of 2 quarters · filed 2016-11-10 | $10.11K 10-Q · filed 2016-11-10 | $8.98K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$181.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$2.37K 10-Q · filed 2016-08-11 | -$3.49K derived: sum of 3 quarters · filed 2016-08-11 | -$4.09K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$2.18K 10-Q · filed 2015-05-14 | -$3.31K derived: sum of 2 quarters · filed 2015-05-14 | -$3.91K derived: sum of 3 quarters · filed 2015-11-13 | -$4.81K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-12-31 | -$1.12K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$1.73K derived: sum of 2 quarters · filed 2015-11-13 | -$2.62K derived: sum of 3 quarters · filed 2015-11-13 | $47.94K 10-K · filed 2015-03-30 |
| 2014-09-30 | -$604.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$1.50K derived: sum of 2 quarters · filed 2015-11-13 | $49.06K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$896.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $49.67K 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $50.56K 10-Q · filed 2015-05-14 | |||
| 2013-12-31 | -$14.82K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |